drugset / Trial / NCT00195520

Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function

NCT00195520 ↗

Phase 4 Completed 100 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the tolerability, bleeding patterns and acceptability of Totelle® 1mg administered to a population of Brazilian women in a continuous combined regime for hormone replacement therapy.

Timeline

Start
2004-12
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Totelle® Unknown 1 mg —

Indications